Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment. - Podder V; Grisham RN; Coleman RL; Cobb LP; Monk BJ; Herzog TJ; Gershenson DM; Slomovitz BM (International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2025)